Index S&P 500
P/E 17.23
EPS (ttm) 7.41
Insider Own 1.67%
Shs Outstand 88.82M
Perf Week -3.35%
Market Cap 11.19B
Forward P/E 12.21
EPS next Y 10.46
Insider Trans -8.84%
Shs Float 86.23M
Perf Month -6.85%
Income 691.53M
PEG 1.15
EPS next Q 1.95
Inst Own 91.98%
Short Float 4.80%
Perf Quarter 21.97%
Sales 12.14B
P/S 0.92
EPS this Y 9.81%
Inst Trans -2.64%
Short Ratio 4.91
Perf Half Y 71.17%
Book/sh 11.89
P/B 10.74
EPS next Y 12.42%
ROA 3.92%
Short Interest 4.14M
Perf Year 52.21%
Cash/sh 5.43
P/C 23.51
EPS next 5Y 15.00%
ROE 78.21%
52W Range 71.51 - 141.54
Perf YTD 21.84%
Dividend Est. -
P/FCF 7.48
EPS past 5Y 51.82%
ROI 5.93%
52W High -9.82%
Beta 1.06
Dividend TTM -
Quick Ratio 1.13
Sales past 5Y 1.27%
Gross Margin 25.33%
52W Low 78.49%
ATR (14) 2.85
Dividend Ex-Date -
Current Ratio 1.19
EPS Y/Y TTM 30.63%
Oper. Margin 13.19%
RSI (14) 36.73
Volatility 2.09% 1.83%
Employees 70000
Debt/Eq 10.53
Sales Y/Y TTM 4.57%
Profit Margin 5.70%
Recom 3.00
Target Price 131.66
Option/Short Yes / Yes
LT Debt/Eq 10.04
EPS Q/Q 173.11%
Payout 0.00%
Rel Volume 0.66
Prev Close 129.78
Sales Surprise 4.57%
EPS Surprise 14.73%
Sales Q/Q 7.85%
Earnings Feb 13 AMC
Avg Volume 842.23K
Price 127.64
SMA20 -5.05%
SMA50 -1.01%
SMA200 20.07%
Trades
Volume 554,965
Change -1.65%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-06-24 Initiated
Barclays
Equal Weight
$133
Aug-07-23 Upgrade
UBS
Neutral → Buy
$100 → $142
Nov-01-22 Downgrade
Deutsche Bank
Buy → Hold
$97 → $72
Oct-31-22 Downgrade
UBS
Buy → Neutral
$117 → $74
Aug-19-22 Resumed
UBS
Buy
$106 → $117
Jun-21-22 Reiterated
BofA Securities
Underperform
$110 → $90
Sep-10-21 Initiated
Cowen
Market Perform
$145
Aug-12-21 Downgrade
Barclays
Overweight → Equal Weight
$135 → $146
Mar-26-21 Downgrade
BofA Securities
Neutral → Underperform
$127 → $118
Jan-05-21 Downgrade
BofA Securities
Buy → Neutral
$127
Jan-24-20 Upgrade
Goldman
Neutral → Buy
$72 → $97
Nov-07-19 Downgrade
Raymond James
Outperform → Mkt Perform
Oct-25-19 Downgrade
Wolfe Research
Outperform → Peer Perform
Sep-11-19 Downgrade
William Blair
Outperform → Mkt Perform
Jul-26-19 Downgrade
Robert W. Baird
Outperform → Neutral
$70 → $65
Jan-08-19 Upgrade
UBS
Sell → Neutral
Jan-03-19 Initiated
Deutsche Bank
Buy
$60
Dec-14-18 Initiated
Barclays
Overweight
Nov-28-18 Upgrade
Raymond James
Mkt Perform → Outperform
Nov-16-18 Initiated
UBS
Sell
$64
Show Previous Ratings
Apr-17-24 07:31PM
Apr-12-24 05:50PM
Apr-10-24 01:35PM
09:40AM
09:00AM
09:00AM
Loading…
09:00AM
Apr-08-24 06:00PM
Apr-02-24 09:40AM
Mar-25-24 10:59AM
10:46AM
09:40AM
Mar-24-24 05:49AM
Mar-22-24 09:52AM
Mar-21-24 12:00PM
Mar-19-24 05:10AM
09:40AM
Loading…
Mar-15-24 09:40AM
Mar-14-24 11:30AM
Mar-11-24 04:40PM
Mar-08-24 05:20PM
09:40AM
05:44AM
Mar-06-24 10:09AM
09:49AM
09:15AM
Mar-05-24 04:50PM
04:19PM
(Investor's Business Daily)
03:34PM
(The Wall Street Journal)
10:08AM
09:00AM
Feb-29-24 07:19PM
11:23PM
Loading…
Feb-28-24 11:23PM
Feb-27-24 07:47AM
Feb-23-24 12:00PM
Feb-22-24 10:31AM
09:50AM
Feb-21-24 12:20PM
09:40AM
Feb-20-24 01:53AM
Feb-15-24 09:15AM
08:50AM
12:22AM
Feb-14-24 07:08PM
11:44AM
09:10AM
Feb-13-24 08:14PM
08:00PM
05:20PM
04:50PM
(Associated Press Finance)
04:36PM
04:08PM
Feb-12-24 06:02AM
Feb-09-24 10:51AM
06:15AM
Feb-01-24 09:40AM
Jan-31-24 03:55PM
Jan-23-24 02:00PM
Jan-22-24 09:50AM
Jan-19-24 09:40AM
Jan-16-24 09:40AM
Dec-30-23 09:26AM
04:30AM
Dec-29-23 12:34PM
Dec-26-23 09:59AM
Dec-25-23 09:40AM
Dec-19-23 10:00AM
Dec-08-23 09:40AM
Dec-07-23 11:31AM
Nov-30-23 10:00AM
Nov-28-23 06:30AM
04:03AM
Nov-27-23 11:20AM
09:07AM
Nov-22-23 10:40AM
09:40AM
Nov-15-23 11:54PM
Nov-13-23 09:31AM
(Yahoo Finance Video) +6.49%
Nov-10-23 12:00PM
Nov-09-23 09:55AM
Nov-08-23 05:46PM
12:22PM
10:56AM
07:27AM
(Thomson Reuters StreetEvents)
01:33AM
(Thomson Reuters StreetEvents)
Nov-07-23 10:07PM
08:30PM
04:44PM
04:40PM
(Associated Press Finance)
04:05PM
09:40AM
Nov-06-23 09:40AM
Nov-03-23 12:21PM
Nov-02-23 12:05PM
Oct-25-23 12:33PM
Oct-24-23 07:00AM
Oct-23-23 10:15AM
09:40AM
08:00AM
Oct-20-23 09:40AM
Oct-18-23 04:52PM
12:00PM
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
STAFFIERI MICHAEL DAVID Chief Operating Officer, DKC Mar 13 '24 Option Exercise 52.41 50,000 2,620,500 102,748 Mar 15 06:13 PM Rodriguez Javier Chief Executive Officer Mar 06 '24 Option Exercise 67.80 750,000 50,850,000 1,244,480 Mar 08 05:04 PM ACKERMAN JOEL CFO and Treasuer Mar 06 '24 Option Exercise 52.41 55,000 2,882,550 195,360 Mar 08 05:04 PM STAFFIERI MICHAEL DAVID Chief Operating Officer, DKC Mar 06 '24 Option Exercise 52.41 50,000 2,620,500 87,687 Mar 08 05:05 PM Rodriguez Javier Chief Executive Officer Feb 28 '24 Option Exercise 67.80 50,000 3,390,000 531,300 Feb 28 05:51 PM Rodriguez Javier Chief Executive Officer Feb 27 '24 Sale 126.87 7,397 938,467 481,300 Feb 28 05:51 PM Rodriguez Javier Chief Executive Officer Feb 26 '24 Option Exercise 67.80 450,000 30,510,000 889,002 Feb 28 05:51 PM Rodriguez Javier Chief Executive Officer Feb 26 '24 Sale 126.11 67,603 8,525,130 488,697 Feb 28 05:51 PM STAFFIERI MICHAEL DAVID Chief Operating Officer, DKC Feb 21 '24 Option Exercise 52.41 100,000 5,241,000 137,687 Feb 23 05:44 PM ACKERMAN JOEL CFO and Treasuer Feb 21 '24 Option Exercise 52.41 55,000 2,882,550 178,726 Feb 23 05:43 PM Waters Kathleen Alyce Chief Legal & Pub. Affairs Off Feb 21 '24 Option Exercise 52.41 40,000 2,096,400 121,297 Feb 23 05:44 PM STAFFIERI MICHAEL DAVID Chief Operating Officer, DKC Feb 21 '24 Sale 119.81 29,488 3,533,025 37,687 Feb 23 05:44 PM Waters Kathleen Alyce Chief Legal & Pub. Affairs Off Feb 21 '24 Sale 120.73 11,285 1,362,438 81,297 Feb 23 05:44 PM HEARTY JAMES O Chief Compliance Officer Feb 16 '24 Option Exercise 54.40 54,608 2,970,478 78,448 Feb 20 08:37 PM HEARTY JAMES O Chief Compliance Officer Feb 16 '24 Sale 119.64 26,164 3,130,269 20,264 Feb 20 08:37 PM Rodriguez Javier Chief Executive Officer Dec 14 '23 Option Exercise 67.80 500,000 33,900,000 833,299 Dec 18 06:44 PM Waters Kathleen Alyce Chief Legal & Pub. Affairs Off Aug 22 '23 Option Exercise 52.41 40,000 2,096,400 121,297 Aug 24 06:54 PM Waters Kathleen Alyce Chief Legal & Pub. Affairs Off Aug 22 '23 Sale 101.81 9,794 997,099 81,297 Aug 24 06:54 PM YALE PHYLLIS R Director May 12 '23 Option Exercise 66.29 7,165 474,968 20,275 May 12 09:31 PM YALE PHYLLIS R Director May 12 '23 Sale 95.26 2,196 209,195 13,110 May 12 09:31 PM STAFFIERI MICHAEL DAVID Chief Operating Officer, DKC May 10 '23 Option Exercise 66.29 243,994 16,174,362 348,071 May 12 09:34 PM Rodriguez Javier Chief Executive Officer May 10 '23 Option Exercise 66.29 88,213 5,847,640 403,835 May 12 09:20 PM ACKERMAN JOEL CFO and Treasuer May 10 '23 Option Exercise 66.29 56,306 3,732,525 191,097 May 12 08:44 PM Waters Kathleen Alyce Chief Legal & Pub. Affairs Off May 10 '23 Option Exercise 66.29 33,784 2,239,541 135,164 May 12 09:15 PM HEARTY JAMES O Chief Compliance Officer May 10 '23 Option Exercise 66.29 26,276 1,741,836 58,835 May 12 08:48 PM DESOER BARBARA J Director May 10 '23 Option Exercise 66.29 7,165 474,968 7,165 May 12 08:46 PM NEHRA JOHN M Director May 10 '23 Option Exercise 66.29 7,165 474,968 7,165 May 12 08:50 PM Rodriguez Javier Chief Executive Officer May 10 '23 Sale 99.44 16,916 1,682,089 315,622 May 12 09:20 PM Waters Kathleen Alyce Chief Legal & Pub. Affairs Off May 10 '23 Sale 99.24 15,941 1,581,990 91,245 May 12 09:15 PM HEARTY JAMES O Chief Compliance Officer May 10 '23 Sale 101.64 5,745 583,914 32,559 May 12 08:48 PM DESOER BARBARA J Director May 10 '23 Sale 101.61 2,449 248,843 0 May 12 08:46 PM
Index S&P 500
P/E 19.90
EPS (ttm) 17.39
Insider Own 1.82%
Shs Outstand 292.50M
Perf Week -3.29%
Market Cap 98.17B
Forward P/E 10.82
EPS next Y 32.00
Insider Trans -3.07%
Shs Float 278.49M
Perf Month -1.86%
Income 5.16B
PEG 1.67
EPS next Q 6.22
Inst Own 91.60%
Short Float 2.00%
Perf Quarter 12.19%
Sales 195.19B
P/S 0.50
EPS this Y 13.29%
Inst Trans -1.54%
Short Ratio 3.52
Perf Half Y 10.88%
Book/sh 158.03
P/B 2.19
EPS next Y 12.57%
ROA 3.59%
Short Interest 5.57M
Perf Year 33.79%
Cash/sh -
P/C -
EPS next 5Y 11.95%
ROE 11.34%
52W Range 240.50 - 365.71
Perf YTD 15.57%
Dividend Est. 6.76 (1.95%)
P/FCF 9.59
EPS past 5Y 10.54%
ROI 6.90%
52W High -5.37%
Beta 0.59
Dividend TTM 5.09 (1.47%)
Quick Ratio -
Sales past 5Y 48.25%
Gross Margin -
52W Low 43.90%
ATR (14) 5.31
Dividend Ex-Date Mar 05, 2024
Current Ratio 0.77
EPS Y/Y TTM -18.94%
Oper. Margin 4.59%
RSI (14) 39.81
Volatility 1.84% 1.33%
Employees 72500
Debt/Eq 0.68
Sales Y/Y TTM 8.42%
Profit Margin 2.65%
Recom 1.54
Target Price 385.86
Option/Short Yes / Yes
LT Debt/Eq 0.62
EPS Q/Q -8.73%
Payout 28.29%
Rel Volume 0.90
Prev Close 346.85
Sales Surprise 4.58%
EPS Surprise 3.86%
Sales Q/Q 11.65%
Earnings May 02 BMO
Avg Volume 1.58M
Price 346.08
SMA20 -2.98%
SMA50 -0.07%
SMA200 13.43%
Trades
Volume 1,426,524
Change -0.22%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-06-24 Initiated
Barclays
Overweight
$393
Feb-05-24 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$327 → $354
Feb-05-24 Upgrade
Cantor Fitzgerald
Neutral → Overweight
$334 → $372
Feb-01-24 Upgrade
Deutsche Bank
Hold → Buy
$355 → $370
Jan-04-24 Upgrade
Bernstein
Mkt Perform → Outperform
$330 → $372
Dec-11-23 Upgrade
Jefferies
Hold → Buy
$335 → $341
Aug-18-23 Downgrade
Edward Jones
Buy → Hold
Jun-06-23 Upgrade
BofA Securities
Neutral → Buy
$320
Apr-21-23 Initiated
Cantor Fitzgerald
Neutral
$285
Apr-05-23 Upgrade
Raymond James
Outperform → Strong Buy
$350
Jan-03-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$370 → $355
Nov-23-22 Resumed
Morgan Stanley
Overweight
$318 → $347
Nov-21-22 Downgrade
Raymond James
Strong Buy → Outperform
$370
Jul-14-22 Downgrade
Jefferies
Buy → Hold
$330 → $271
Jun-22-22 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$283 → $296
Jun-17-22 Initiated
Loop Capital
Hold
$270
May-27-22 Resumed
Bernstein
Mkt Perform
$258 → $301
May-26-22 Upgrade
BofA Securities
Underperform → Neutral
$265 → $300
May-16-22 Upgrade
JP Morgan
Neutral → Overweight
$248 → $304
May-09-22 Upgrade
Cowen
Market Perform → Outperform
$242 → $329
Show Previous Ratings
Apr-17-24 12:10PM
Apr-16-24 01:47PM
(The Wall Street Journal)
10:01AM
04:13AM
Apr-15-24 04:46AM
06:15PM
Loading…
Apr-12-24 06:15PM
09:40AM
Apr-11-24 09:00AM
Apr-09-24 01:16PM
Apr-04-24 06:15PM
Apr-03-24 04:09PM
02:46PM
Apr-02-24 04:01PM
(Investor's Business Daily)
11:33AM
07:04AM
03:43PM
Loading…
Apr-01-24 03:43PM
Mar-31-24 11:03PM
Mar-30-24 01:00PM
Mar-28-24 04:05PM
09:33AM
Mar-27-24 06:15PM
09:40AM
Mar-25-24 09:30AM
Mar-24-24 11:00AM
Mar-21-24 08:02PM
Mar-18-24 06:15PM
Mar-14-24 09:15AM
Mar-12-24 06:15PM
10:24AM
Mar-08-24 11:16AM
10:32AM
Loading…
10:32AM
10:15AM
09:13AM
05:31AM
01:57AM
(Thomson Reuters StreetEvents)
Mar-07-24 06:22PM
03:03PM
01:47PM
01:12PM
09:30AM
07:13AM
07:10AM
06:54AM
06:45AM
Mar-06-24 11:56AM
Mar-05-24 10:54AM
Mar-04-24 05:02AM
Mar-01-24 12:07AM
Feb-29-24 09:50AM
Feb-28-24 09:10AM
Feb-27-24 09:40AM
09:15AM
09:00AM
Feb-26-24 04:18PM
Feb-24-24 03:37PM
Feb-21-24 10:07AM
09:12AM
01:34AM
Feb-20-24 04:30PM
12:00PM
07:30AM
Feb-17-24 01:29PM
Feb-15-24 06:00AM
04:51AM
Feb-14-24 01:41PM
Feb-13-24 07:00AM
Feb-11-24 08:00AM
(The Wall Street Journal)
Feb-09-24 09:42AM
Feb-08-24 06:09PM
11:50AM
09:15AM
Feb-06-24 02:00PM
09:40AM
Feb-05-24 01:00PM
10:10AM
08:18AM
Feb-03-24 08:51AM
12:11AM
(Thomson Reuters StreetEvents)
Feb-02-24 07:40PM
(Morningstar Research) +5.38%
03:15PM
03:04PM
01:20PM
12:56PM
12:42PM
10:58AM
10:57AM
(The Wall Street Journal)
10:46AM
10:17AM
10:15AM
09:30AM
09:16AM
07:33AM
07:10AM
06:33AM
06:18AM
(Associated Press Finance)
06:03AM
06:00AM
02:55AM
Feb-01-24 05:23PM
09:58AM
The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Cordani David Chairman & CEO Mar 26 '24 Option Exercise 139.22 7,761 1,080,486 355,815 Mar 28 05:14 PM Cordani David Chairman & CEO Mar 25 '24 Option Exercise 139.22 31,209 4,344,917 379,263 Mar 25 06:19 PM Cordani David Chairman & CEO Mar 25 '24 Sale 355.17 31,209 11,084,357 348,054 Mar 25 06:19 PM Cordani David Chairman & CEO Mar 22 '24 Option Exercise 139.22 6,338 882,376 354,392 Mar 25 06:19 PM Cordani David Chairman & CEO Mar 22 '24 Sale 355.11 6,338 2,250,682 348,054 Mar 25 06:19 PM Cordani David Chairman & CEO Mar 21 '24 Option Exercise 139.22 2,293 319,231 350,347 Mar 25 06:19 PM Cordani David Chairman & CEO Mar 21 '24 Sale 355.02 2,293 814,052 348,054 Mar 25 06:19 PM Cordani David Chairman & CEO Mar 14 '24 Option Exercise 139.22 7,616 1,060,300 348,054 Mar 14 06:09 PM Cordani David Chairman & CEO Mar 13 '24 Option Exercise 139.22 13,761 1,915,806 354,199 Mar 14 06:09 PM Cordani David Chairman & CEO Mar 13 '24 Sale 347.33 13,761 4,779,542 340,438 Mar 14 06:09 PM Cordani David Chairman & CEO Mar 12 '24 Option Exercise 139.22 2,238 311,574 342,676 Mar 14 06:09 PM Cordani David Chairman & CEO Mar 12 '24 Sale 345.00 2,238 772,121 340,438 Mar 14 06:09 PM Cordani David Chairman & CEO Mar 08 '24 Option Exercise 139.22 2,801 389,955 343,239 Mar 11 05:38 PM Cordani David Chairman & CEO Mar 08 '24 Sale 345.19 2,801 966,883 340,438 Mar 11 05:38 PM Cordani David Chairman & CEO Mar 07 '24 Option Exercise 139.22 2,412 335,799 342,850 Mar 11 05:38 PM Cordani David Chairman & CEO Mar 07 '24 Sale 345.73 2,412 833,892 340,438 Mar 11 05:38 PM Cordani David Chairman & CEO Mar 04 '24 Sale 332.62 19,288 6,415,575 340,438 Mar 05 05:43 PM Jones Nicole S See Remarks Mar 04 '24 Sale 332.62 4,436 1,475,502 31,587 Mar 05 05:43 PM Triplett Michael W Special Advisor Mar 04 '24 Sale 332.62 1,953 649,607 32,452 Mar 05 05:43 PM Cordani David Chairman & CEO Feb 27 '24 Option Exercise 139.22 2,000 278,440 338,783 Feb 27 05:48 PM Cordani David Chairman & CEO Feb 27 '24 Sale 345.04 2,000 690,075 336,783 Feb 27 05:48 PM Cordani David Chairman & CEO Feb 26 '24 Option Exercise 139.22 10,453 1,455,267 347,236 Feb 27 05:48 PM Cordani David Chairman & CEO Feb 26 '24 Sale 345.70 10,453 3,613,652 336,783 Feb 27 05:48 PM Cordani David Chairman & CEO Feb 23 '24 Option Exercise 139.22 6,319 879,731 343,102 Feb 27 05:48 PM Cordani David Chairman & CEO Feb 23 '24 Sale 345.24 6,319 2,181,592 336,783 Feb 27 05:48 PM Palmer Eric P See Remarks Feb 14 '24 Option Exercise 149.13 905 134,967 45,554 Feb 15 05:30 PM Cordani David Chairman & CEO Feb 13 '24 Option Exercise 139.22 7,462 1,038,860 336,783 Feb 13 05:27 PM Palmer Eric P See Remarks Feb 13 '24 Option Exercise 149.13 5,168 770,730 50,732 Feb 15 05:30 PM Palmer Eric P See Remarks Feb 13 '24 Sale 340.00 6,083 2,068,220 44,649 Feb 15 05:30 PM Cordani David Chairman & CEO Feb 12 '24 Option Exercise 139.22 2,073 288,603 331,394 Feb 13 05:27 PM Cordani David Chairman & CEO Feb 12 '24 Sale 336.81 2,073 698,198 329,321 Feb 13 05:27 PM Cordani David Chairman & CEO Feb 09 '24 Option Exercise 139.22 38,065 5,299,409 367,386 Feb 13 05:27 PM Cordani David Chairman & CEO Feb 09 '24 Sale 335.22 38,065 12,760,123 329,321 Feb 13 05:27 PM Palmer Eric P See Remarks Feb 09 '24 Sale 335.26 1,017 340,956 45,564 Feb 13 05:28 PM Agoglia Hoeltzel Mary T SVP Tax & Chief Acct. Officer Feb 07 '24 Option Exercise 78.03 4,867 379,796 6,969 Feb 09 05:04 PM Agoglia Hoeltzel Mary T SVP Tax & Chief Acct. Officer Feb 07 '24 Sale 330.48 4,867 1,608,446 2,102 Feb 09 05:04 PM Palmer Eric P See Remarks Feb 05 '24 Option Exercise 139.22 1,017 141,587 46,581 Feb 06 09:02 PM Palmer Eric P See Remarks Feb 02 '24 Option Exercise 139.22 5,684 791,326 51,248 Feb 06 09:02 PM Palmer Eric P See Remarks Feb 02 '24 Sale 325.00 5,684 1,847,300 45,564 Feb 06 09:02 PM Ryan Cynthia EVP, CHRO Aug 30 '23 Option Exercise 149.13 434 64,725 5,937 Aug 31 05:33 PM Ryan Cynthia EVP, CHRO Aug 29 '23 Option Exercise 149.13 3,012 449,195 9,271 Aug 31 05:33 PM Ryan Cynthia EVP, CHRO Aug 29 '23 Sale 282.22 3,768 1,063,405 5,503 Aug 31 05:33 PM Jones Nicole S EVP, General Counsel Aug 21 '23 Sale 276.86 7,819 2,164,768 30,069 Aug 23 05:19 PM Agoglia Hoeltzel Mary T SVP Tax & Chief Acct. Officer Aug 08 '23 Option Exercise 78.03 4,500 351,158 14,343 Aug 10 05:07 PM Agoglia Hoeltzel Mary T SVP Tax & Chief Acct. Officer Aug 08 '23 Sale 291.00 12,250 3,564,750 2,093 Aug 10 05:07 PM Evanko Brian C EVP, Chief Financial Officer Aug 03 '23 Option Exercise 78.03 570 44,480 31,902 Aug 04 05:21 PM Evanko Brian C EVP, Chief Financial Officer Aug 02 '23 Option Exercise 78.03 2,307 180,027 33,639 Aug 04 05:21 PM Evanko Brian C EVP, Chief Financial Officer Aug 02 '23 Sale 300.00 2,307 692,100 31,332 Aug 04 05:21 PM Neville Everett EVP, Solutions & Corp Devt. Jul 20 '23 Option Exercise 211.14 1,050 221,701 5,987 Jul 21 05:03 PM Neville Everett EVP, Solutions & Corp Devt. Jul 19 '23 Option Exercise 213.05 13,157 2,803,077 18,094 Jul 21 05:03 PM Neville Everett EVP, Solutions & Corp Devt. Jul 19 '23 Sale 295.21 13,157 3,884,078 4,937 Jul 21 05:03 PM Sanford Paul A EVP Operations Jul 19 '23 Sale 295.21 1,507 444,881 8,679 Jul 21 05:03 PM Neville Everett EVP, Solutions & Corp Devt. Jul 10 '23 Sale 277.61 466 129,366 4,937 Jul 12 06:43 PM ZARCONE DONNA F Director May 01 '23 Sale 253.29 757 191,741 25,558 May 03 05:22 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite